You have 1 action to finish to complete your account. Craft your experience by picking your interest on the Personalisation Page
Pulmonology

ERS 2023 | Heterogeneity of Inflammatory Pathways in COPD

Dr. Stephanie Christenson shares an overview of inflammatory pathways underlying COPD, including type 2 inflammation.

Stephanie  Christenson
MAS, MD
Stephanie Christenson

Learning objectives

  • Describe the clinical consequences of COPD through an understanding of pathological changes
  • Understand the spectrum of inflammatory pathways and the role of type 2 inflammation in COPD pathophysiology

Description

Join Klaus Rabe, MD, PhD, and Stephanie Christenson, MD, PhD, as they dive into the intricate relationship between clinical presentation and disease pathology in COPD and shed light on the diverse inflammatory pathways that contribute to its heterogeneity. Their discussion offers valuable insights into understanding the complexity of inflammatory mechanisms driving COPD.

MAT-US-2401136 v1.0 - P Exp Date: 11/28/2025

About this expert

Pulmonology

Stephanie Christenson

MAS, MD

Associate Professor at the University of California, San Francisco in the Division of Pulmonary, Critical Care, Allergy, and Sleep Medicine

See author’s profile
Stephanie  Christenson

Related resources